(C) BoingBoing
This story was originally published by BoingBoing and is unaltered.
. . . . . . . . . .
One LSD trip shown to provide rapid and lasting reduction in anxiety, FDA designates "breakthrough therapy" [1]
['David Pescovitz']
Date: 2024-03-07
The US Food and Drug Administration has granted a "breakthrough therapy" designation to a formulation of LSD shown to treat generalized anxiety disorder. The decision was based on clinical trials that showed the drug "exhibited rapid and robust efficacy" in reducing anxiety, "solidly sustained for 12 weeks after a single dose."
"A breakthrough designation is a recognition that a drug has demonstrated evidence of clinical efficacy in meeting an unmet medical need with morbidity and mortality associated with it," said Tufts University School of Medicine psychiatrist Daniel Karlin who is chief medical officer for MindMed, the company developing the drug.
From CNN:
[END]
---
[1] Url:
https://boingboing.net/2024/03/07/one-lsd-trip-shown-to-provide-rapid-and-lasting-reduction-in-anxiety-fda-designates-breakthrough-therapy.html
Published and (C) by BoingBoing
Content appears here under this condition or license: Creative Commons BY-NC-SA 3.0.
via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/boingboing/
